Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HDN1
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0032446 | protein modification by small protein conjugation | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045116 | protein neddylation | 7 | 1 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016874 | ligase activity | 2 | 8 |
GO:0016740 | transferase activity | 2 | 5 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 4 |
GO:0019788 | NEDD8 transferase activity | 4 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 4 |
GO:0000166 | nucleotide binding | 3 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0005524 | ATP binding | 5 | 3 |
GO:0017076 | purine nucleotide binding | 4 | 3 |
GO:0030554 | adenyl nucleotide binding | 5 | 3 |
GO:0032553 | ribonucleotide binding | 3 | 3 |
GO:0032555 | purine ribonucleotide binding | 4 | 3 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 3 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 3 |
GO:0036094 | small molecule binding | 2 | 3 |
GO:0043167 | ion binding | 2 | 3 |
GO:0043168 | anion binding | 3 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:0097367 | carbohydrate derivative binding | 2 | 3 |
GO:1901265 | nucleoside phosphate binding | 3 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
GO:0019789 | SUMO transferase activity | 4 | 2 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 1 |
GO:0016746 | acyltransferase activity | 3 | 1 |
GO:0061631 | ubiquitin conjugating enzyme activity | 5 | 1 |
GO:0061650 | ubiquitin-like protein conjugating enzyme activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.283 |
CLV_NRD_NRD_1 | 183 | 185 | PF00675 | 0.201 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.586 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.376 |
CLV_PCSK_KEX2_1 | 183 | 185 | PF00082 | 0.273 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.190 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.595 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.363 |
DEG_SPOP_SBC_1 | 23 | 27 | PF00917 | 0.539 |
DOC_MAPK_gen_1 | 121 | 128 | PF00069 | 0.193 |
DOC_MAPK_MEF2A_6 | 121 | 130 | PF00069 | 0.256 |
DOC_MAPK_MEF2A_6 | 141 | 149 | PF00069 | 0.298 |
DOC_PP1_RVXF_1 | 86 | 92 | PF00149 | 0.367 |
DOC_PP4_FxxP_1 | 151 | 154 | PF00568 | 0.259 |
DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.628 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.556 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.412 |
LIG_14-3-3_CanoR_1 | 88 | 97 | PF00244 | 0.354 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.621 |
LIG_BRCT_BRCA1_1 | 91 | 95 | PF00533 | 0.376 |
LIG_FHA_1 | 135 | 141 | PF00498 | 0.267 |
LIG_FHA_2 | 137 | 143 | PF00498 | 0.376 |
LIG_LIR_Apic_2 | 148 | 154 | PF02991 | 0.259 |
LIG_LIR_Apic_2 | 94 | 100 | PF02991 | 0.332 |
LIG_LIR_Gen_1 | 176 | 186 | PF02991 | 0.376 |
LIG_LIR_Nem_3 | 176 | 181 | PF02991 | 0.376 |
LIG_LIR_Nem_3 | 63 | 69 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 72 | 76 | PF02991 | 0.345 |
LIG_LIR_Nem_3 | 84 | 90 | PF02991 | 0.332 |
LIG_PDZ_Class_2 | 187 | 192 | PF00595 | 0.610 |
LIG_Pex14_2 | 87 | 91 | PF04695 | 0.259 |
LIG_SH2_CRK | 104 | 108 | PF00017 | 0.341 |
LIG_SH2_CRK | 73 | 77 | PF00017 | 0.267 |
LIG_SH2_CRK | 97 | 101 | PF00017 | 0.406 |
LIG_SH2_SRC | 156 | 159 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.249 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.376 |
LIG_SUMO_SIM_par_1 | 142 | 148 | PF11976 | 0.334 |
LIG_TYR_ITIM | 71 | 76 | PF00017 | 0.267 |
LIG_WRC_WIRS_1 | 35 | 40 | PF05994 | 0.558 |
MOD_CDK_SPxK_1 | 71 | 77 | PF00069 | 0.275 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.637 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.635 |
MOD_CK2_1 | 173 | 179 | PF00069 | 0.364 |
MOD_Cter_Amidation | 119 | 122 | PF01082 | 0.175 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.488 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.551 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.584 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.285 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.637 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.694 |
MOD_N-GLC_1 | 28 | 33 | PF02516 | 0.766 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.560 |
MOD_NEK2_2 | 136 | 141 | PF00069 | 0.275 |
MOD_PKA_2 | 102 | 108 | PF00069 | 0.283 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.283 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.522 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.412 |
MOD_SUMO_for_1 | 171 | 174 | PF00179 | 0.283 |
MOD_SUMO_rev_2 | 53 | 61 | PF00179 | 0.412 |
TRG_DiLeu_BaEn_1 | 9 | 14 | PF01217 | 0.475 |
TRG_DiLeu_BaLyEn_6 | 85 | 90 | PF01217 | 0.175 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.326 |
TRG_ER_diArg_1 | 107 | 109 | PF00400 | 0.355 |
TRG_ER_diArg_1 | 183 | 185 | PF00400 | 0.202 |
TRG_NES_CRM1_1 | 142 | 157 | PF08389 | 0.376 |
TRG_NES_CRM1_1 | 50 | 65 | PF08389 | 0.259 |
TRG_Pf-PMV_PEXEL_1 | 11 | 15 | PF00026 | 0.598 |
TRG_Pf-PMV_PEXEL_1 | 77 | 81 | PF00026 | 0.312 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HXA7 | Leptomonas seymouri | 27% | 71% |
A0A0N1IA93 | Leptomonas seymouri | 74% | 100% |
A0A0N1PB60 | Leptomonas seymouri | 28% | 100% |
A0A0S4JS17 | Bodo saltans | 27% | 100% |
A0A0S4KJ33 | Bodo saltans | 29% | 100% |
A0A1X0NT81 | Trypanosomatidae | 26% | 92% |
A0A1X0NVW4 | Trypanosomatidae | 47% | 89% |
A0A3Q8II46 | Leishmania donovani | 29% | 100% |
A0A3R7M279 | Trypanosoma rangeli | 44% | 96% |
A0A3S5H5C0 | Leishmania donovani | 28% | 100% |
A0A3S7WX16 | Leishmania donovani | 28% | 74% |
A0A3S7WYH9 | Leishmania donovani | 91% | 100% |
A0A422MVJ2 | Trypanosoma rangeli | 29% | 100% |
A0A422NDI3 | Trypanosoma rangeli | 26% | 91% |
A0A451EJH5 | Leishmania donovani | 33% | 100% |
A3KN22 | Bos taurus | 31% | 100% |
A4H3D5 | Leishmania braziliensis | 31% | 100% |
A4H402 | Leishmania braziliensis | 28% | 100% |
A4HCA6 | Leishmania braziliensis | 28% | 74% |
A4HMF2 | Leishmania braziliensis | 33% | 100% |
A4HRN6 | Leishmania infantum | 33% | 100% |
A4HS64 | Leishmania infantum | 28% | 100% |
A4HZT8 | Leishmania infantum | 28% | 74% |
A4IB24 | Leishmania infantum | 29% | 100% |
A7SE05 | Nematostella vectensis | 24% | 94% |
C9ZRM5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 86% |
C9ZWD4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 97% |
E9AH78 | Leishmania infantum | 91% | 100% |
E9AK51 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AVP3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 74% |
E9AX16 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
E9B609 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
O13685 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 100% |
O74549 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 31% | 100% |
P16577 | Triticum aestivum | 30% | 100% |
P42748 | Arabidopsis thaliana | 30% | 100% |
P42749 | Arabidopsis thaliana | 30% | 100% |
P42750 | Arabidopsis thaliana | 27% | 100% |
P52486 | Drosophila melanogaster | 28% | 96% |
P52491 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 27% | 100% |
P61081 | Homo sapiens | 31% | 100% |
P61082 | Mus musculus | 31% | 100% |
P61088 | Homo sapiens | 28% | 100% |
P61089 | Mus musculus | 28% | 100% |
P63146 | Homo sapiens | 27% | 100% |
P63147 | Mus musculus | 27% | 100% |
P63148 | Oryctolagus cuniculus | 27% | 100% |
P63149 | Rattus norvegicus | 27% | 100% |
Q08BH7 | Danio rerio | 29% | 99% |
Q0P5K3 | Bos taurus | 28% | 100% |
Q32LD2 | Bos taurus | 27% | 98% |
Q32P99 | Bos taurus | 27% | 100% |
Q4QAG0 | Leishmania major | 92% | 100% |
Q4QBT6 | Leishmania major | 28% | 74% |
Q4R4I1 | Macaca fascicularis | 28% | 100% |
Q54TI6 | Dictyostelium discoideum | 32% | 83% |
Q5R7J6 | Pongo abelii | 28% | 100% |
Q6C9W0 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 28% | 100% |
Q6CSW8 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 30% | 100% |
Q6DCZ9 | Xenopus laevis | 32% | 100% |
Q6FVQ8 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 29% | 100% |
Q6P8D9 | Xenopus tropicalis | 32% | 100% |
Q75AF2 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 28% | 100% |
Q7ZY08 | Xenopus laevis | 31% | 100% |
Q9EQX9 | Rattus norvegicus | 28% | 100% |
Q9GNC1 | Leishmania major | 29% | 97% |
Q9LJD7 | Arabidopsis thaliana | 28% | 100% |
Q9NED4 | Leishmania major | 28% | 100% |
Q9NPD8 | Homo sapiens | 28% | 97% |
Q9SDY5 | Arabidopsis thaliana | 32% | 100% |
Q9UTN8 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 31% | 100% |
Q9VSF3 | Drosophila melanogaster | 30% | 100% |
Q9W6H5 | Danio rerio | 33% | 100% |
Q9ZU75 | Arabidopsis thaliana | 30% | 100% |
V5BVS1 | Trypanosoma cruzi | 32% | 86% |